the introduced Cutting Copays Act would cut the cost of generic prescription drugs to $0 for over 270,000 Kentucky seniors and people with disabilities
Eliminate all copays on generic prescription drugs for seniors and people with disabilities enrolled in Medicare Part D's Low Income Subsidy program.
Occurrences
H.R.4139 - 119th Congress (2025-2026): Cutting Copays Act | Congress.gov | Library of Congress; McGarvey, Morgan [D-KY] (118th-119th)
Evidence
Medicare.gov states that under Extra Help in 2026, beneficiaries pay a $0 premium and $0 deductible, but prescriptions at participating pharmacies can cost up to $5.10 for each generic drug. It also says beneficiaries pay $0 only after total drug costs reach $2,100, and QMB beneficiaries may still pay up to $4.90 for covered drugs.
Congress.gov lists H.R.3069, the Medicare for All Act, as introduced on 2025-04-29 and referred to House committees. It lists Rep. Morgan McGarvey as an original cosponsor on 2025-04-29. The bill status is Introduced, not enacted.
The bill text includes outpatient prescription drugs among covered benefits and says no cost-sharing, including deductibles, coinsurance, copayments, or similar charges, may be imposed for benefits under the Act.
Congress.gov lists H.R.3421, the Medicare for All Act, as introduced on 2023-05-17, with Rep. Morgan McGarvey as an original cosponsor on 2023-05-17. The latest action was referral to the Subcommittee on Health on 2024-12-17, and the tracker status remained Introduced.
The 118th Congress bill text included outpatient prescription drugs in comprehensive benefits and barred cost-sharing, including copayments, for benefits provided under the Act.
McGarvey's campaign health-care page says he supports Medicare for All, Medicare drug-price negotiation, and access to affordable prescription medication. The page does not state the specific Medicare Part D Low Income Subsidy generic-copay pledge verbatim.
Assessments
The promised outcome has not been delivered: current Medicare Extra Help/LIS rules for 2026 still allow generic prescription copays, up to $5.10 before the applicable threshold. McGarvey did materially pursue related legislation by cosponsoring Medicare for All Act bills in the 118th and 119th Congresses that would bar prescription drug cost-sharing if enacted, but those bills remained introduced/not enacted. Because there was a serious legislative attempt without enactment of the specific copay elimination, this is a failed promise with an effort badge rather than partial delivery.